Champions Oncology (CSBR) Cash from Operations Growth (5y) (2015 - 2026)
Champions Oncology (CSBR) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Champions Oncology |
78.46 Mn |
71.46 Mn |
13.89 Mn |
| Date | Value |
|---|
| Jan 31, 2026 |
-64.15% |
| Oct 31, 2025 |
-31.78% |
| Jul 31, 2025 |
23.21% |
| Apr 30, 2025 |
21.96% |
| Jan 31, 2025 |
11.92% |
| Oct 31, 2024 |
-22.74% |
| Jul 31, 2024 |
25.51% |
| Apr 30, 2024 |
-55.89% |
| Jan 31, 2024 |
-22.51% |
| Oct 31, 2023 |
55.88% |
| Jul 31, 2023 |
-69.23% |
| Apr 30, 2023 |
-139.55% |
| Jan 31, 2023 |
28.73% |
| Oct 31, 2022 |
65.08% |
| Jul 31, 2022 |
36.89% |
| Apr 30, 2022 |
14.87% |
| Jan 31, 2022 |
52.41% |
| Oct 31, 2021 |
60.31% |
| Jul 31, 2021 |
15.87% |
| Apr 30, 2021 |
-28.97% |
